Last edition
News about "Organon"
Organon Wins FDA Approval to Extend Duration of Use for NEXPLANON
Organon has received US Food and Drug Administration (FDA) approval for a supplemental New Drug Application extending the duration of use of NEXPLANON, its etonogestrel radiopaque contraceptive implant, to up to five years, expanding the product’s earlier three-year indication and offering longer-lasting contraceptive protection.
Organon | 17/01/2026 | By News Bureau | 272
Organon to Market Bempedoic Acid Therapy Nilemdo in Key European Markets
Organon, a global healthcare company focused on delivering impactful medicines and solutions for everyday health, has entered into an agreement with Daiichi Sankyo Europe to commercialize Nilemdo (bempedoic acid) across France, Denmark, Iceland, Sweden, Finland, and Norway.
Organon | 11/01/2026 | By Darshana | 156
Organon Announces Agreement to Divest its JADA System for up to USD 465 Million to Laborie
Organon has entered into a definitive agreement to divest its JADA System to Laborie for up to USD 465 million. The deal aims to leverage Laborie’s expertise in medical technology to expand the reach of JADA, enhancing access to postpartum hemorrhage treatment for mothers worldwide.
Organon | 11/11/2025 | By Dineshwori | 221
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy